Copyright
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 6, 2025; 13(31): 108426
Published online Nov 6, 2025. doi: 10.12998/wjcc.v13.i31.108426
Published online Nov 6, 2025. doi: 10.12998/wjcc.v13.i31.108426
Recognizing and addressing the challenges of concomitant cerebrocardiac infarction
Xu Tian, Nan Zhang, Tong Liu, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin 300211, China
Co-first authors: Xu Tian and Nan Zhang.
Author contributions: Tian X and Zhang N jointly reviewed the relevant literature and preliminarily completed the manuscript following discussions, and they contributed equally to this article, as the co-first authors of this manuscript; Liu T provided constructive feedback to refine the manuscript, enhancing its overall quality and coherence; and all authors thoroughly reviewed and endorsed the final manuscript.
Supported by the National Natural Science Foundation of China, No. 82170327 and No. 82370332; and Tianjin Key Medical Discipline (Specialty) Construction Project, No. TJYXZDXK-029A.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tong Liu, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, No. 23 Pingjiang Road, Hexi District, Tianjin 300211, China. liutongdoc@126.com
Received: April 14, 2025
Revised: May 26, 2025
Accepted: August 26, 2025
Published online: November 6, 2025
Processing time: 199 Days and 15.4 Hours
Revised: May 26, 2025
Accepted: August 26, 2025
Published online: November 6, 2025
Processing time: 199 Days and 15.4 Hours
Core Tip
Core Tip: Concomitant cerebrocardiac ischemic is a rare but urgent condition with extremely high mortality. The management of concomitant concomitant cerebrocardiac ischemic has some dilemmas. In the acute phase, the physicians must decide which disease to treat first, which is related to the severity of the heart and brain lesions. In chronic phases, the use of antiplatelet agents and drugs that improve myocardial remodeling remains controversial. The neurologists and cardiologists should make treatment decisions together.